Should current guidelines lower the blood pressure treatment threshold for increased prevention of CVD?

Addressing the gaps in lipoprotein cholesterol (LDL-C) control and statin prescribing among patients with type 2 diabetes.

No differences in the barriers to weight loss and weight loss success were observed between the intermittent (IER) and continuous (CER) dieters.

In addition to clinical trials, does data from a meta-analysis of retrospective cohort studies support the benefits of SGLT-2 inhibitors?

Can we reduce mortality with patients with Covid-19 by controlling blood glucose?

Despite being on first-line oral anti-diabetic drug therapy, the risk of developing CVD/CKD in patients with type 2 diabetes remains high.

The Look AHEAD trial had dramatic results for patients with T2D and their risk for cardiovascular disease (CVD). 

How does intensive medical therapy (IMT) compare with surgical treatment in improving patients' quality of life? 

Black patients may have lower odds of achieving target HbA1C levels on metformin and SGLT2 alone. 

A 16-week low-fat plant-based diet significantly improves diabetes parameters in adult patients with type 2 diabetes mellitus (T2DM).